A Clinical Investigation of Hypoxic Red Blood Cell Administration in Patients with Transfusion-Dependent Hematological Malignancies and Burns
Håkon Reikvam, Turid Helen Felli Lunde, Einar Klæboe Kristoffersen, Laurel Omert, Jill Bagdasarian, Stian K Almeland · 2026
Read A Clinical Investigation of Hypoxic Red Blood Cell Administration in Patients with Transfusion-Dependent Hematological Malignancies and Burns by Håkon Reikvam, Turid Helen Felli Lunde, Einar Klæboe Kristoffersen, Laurel Omert, Jill Bagdasarian, Stian K Almeland (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13271058.txt.
Description
Håkon Reikvam led a 2026 pilot safety study of hypoxic red blood cells, blood stored with oxygen and carbon dioxide removed to keep it in better condition, given by transfusion. Two patient groups were studied: people with blood cancers who need regular transfusions, and people with acute burns having surgery.
Twenty patients aged 27 to 96 received the stored blood, ten in each group. No adverse events linked to the hypoxic blood were reported within 24 hours or up to seven days. Haemoglobin, the oxygen-carrying protein, rose by an average of 1.2 units in the blood cancer group and 0.3 in the burn group soon after transfusion. The authors call the product safe and well tolerated here.
Catalog record
| CREATOR | Håkon Reikvam, Turid Helen Felli Lunde, Einar Klæboe Kristoffersen, Laurel Omert, Jill Bagdasarian, Stian K Almeland |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42798 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |